재고 위치

New Jersey, USA
Czech Republic, EU
Mumbai, India

* 재고 가용성에 따라 다름

Documentation

MSDS 다운로드

샘플 COA 다운로드

포함 사항: HPLC, MASS/LC-MS, 1H NMR, FT-IR, 함량, 구조 규명 보고서(SER), 그리고 제품에 따라 추가 분석 데이터가 제공됩니다.

2864810-38-6Empagliflozin Dimer Impurity

● 재고 있음

카탈로그 번호:	VE008511
CAS 번호:	2864810-38-6
분자식:	C34H32Cl2O4
분자량:	575.5 g/mol

견적 요청

RFQ 목록에 추가

에 대한 추가 정보 CAS 2864810-38-6

모약물

Empagliflozin

IUPAC명

(3S, 3’S)-3, 3′-((((4, 4′-dichloro-[1, 1′-biphenyl]-3, 3′-diyl)bis(methylene))bis(4, 1-phenylene))bis(oxy))bis(tetrahydrofuran)

약전 동의어

N/A

Other Synonyms

Desglucosylempagliflozin 4,4′-DImer

SMILES

ClC1=CC=C(C2=CC=C(Cl)C(CC3=CC=C(O[C@@H]4COCC4)C=C3)=C2)C=C1CC5=CC=C(O[C@@H]6COCC6)C=C5

InChI

InChI=1S/C34H32Cl2O4/c35-33-11-5-25(19-27(33)17-23-1-7-29(8-2-23)39-31-13-15-37-21-31)26-6-12-34(36)28(20-26)18-24-3-9-30(10-4-24)40-32-14-16-38-22-32/h1-12,19-20,31-32H,13-18,21-22H2/t31-,32-/m0/s1

설명

Empagliflozin Dimer ImpurityÂ is an impurity present in Empagliflozin, Empagliflozin is an inhibitor of sodium-glucose co-transporter-2, Empagliflozin lowers blood glucose levels by preventing glucose reabsorption in the kidneys, thereby increasing the amount of glucose excreted in the urine, which is used to manage type 2 diabetes mellitus.

References

“Anderson, J. E., Wright, E. E., & Shaefer, C. F. (2016). Empagliflozin: Role in Treatment Options for Patients with Type 2 Diabetes Mellitus. Diabetes Therapy, 8(1), 33â€“53. https://doi.org/10.1007/s13300-016-0211-x â€Œ”